U.S. flag

An official website of the United States government

NM_001164277.2(SLC37A4):c.1042_1043del (p.Leu348fs) AND Phosphate transport defect

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Feb 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000007337.11

Allele description [Variation Report for NM_001164277.2(SLC37A4):c.1042_1043del (p.Leu348fs)]

NM_001164277.2(SLC37A4):c.1042_1043del (p.Leu348fs)

Gene:
SLC37A4:solute carrier family 37 member 4 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11q23.3
Genomic location:
Preferred name:
NM_001164277.2(SLC37A4):c.1042_1043del (p.Leu348fs)
Other names:
1211delCT; p.Leu370ValfsTer53
HGVS:
  • NC_000011.10:g.119025271_119025272del
  • NG_013331.1:g.10634_10635del
  • NM_001164277.2:c.1042_1043delMANE SELECT
  • NM_001164278.2:c.1108_1109del
  • NM_001164279.2:c.823_824del
  • NM_001164280.2:c.1042_1043del
  • NM_001467.6:c.1042_1043del
  • NP_001157749.1:p.Leu348fs
  • NP_001157749.1:p.Leu348fs
  • NP_001157750.1:p.Leu370fs
  • NP_001157751.1:p.Leu275fs
  • NP_001157752.1:p.Leu348fs
  • NP_001458.1:p.Leu348fs
  • LRG_187t1:c.1042_1043del
  • LRG_187:g.10634_10635del
  • LRG_187p1:p.Leu348fs
  • NC_000011.9:g.118895981_118895982del
  • NC_000011.9:g.118895981_118895982delAG
  • NM_001164277.1:c.1042_1043del
  • NM_001164277.1:c.1042_1043delCT
  • NM_001164278.1:c.1108_1109delCT
  • NM_001164278.2:c.1108_1109del
  • NM_001164280.1:c.1042_1043delCT
  • NM_001467.4:c.1042_1043delCT
  • NM_001467.5:c.1042_1043delCT
  • NM_001467.6:c.1042_1043del
  • NP_001458.1:p.Leu348ValfsTer53
  • p.Leu370ValfsX53
Protein change:
L275fs
Links:
OMIM: 602671.0006; dbSNP: rs80356491
NCBI 1000 Genomes Browser:
rs80356491
Molecular consequence:
  • NM_001164277.2:c.1042_1043del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001164278.2:c.1108_1109del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001164279.2:c.823_824del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001164280.2:c.1042_1043del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001467.6:c.1042_1043del - frameshift variant - [Sequence Ontology: SO:0001589]
Functional consequence:
protein truncation [Variation Ontology: 0015]

Condition(s)

Name:
Phosphate transport defect (GSD1C)
Synonyms:
GLYCOGEN STORAGE DISEASE Ic; GSD Ic
Identifiers:
MedGen: C0342749; Orphanet: 364; Orphanet: 79259; OMIM: 232240

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000027535OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 1999)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV0038418213billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 23, 2023)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.

Veiga-da-Cunha M, Gerin I, Chen YT, de Barsy T, de Lonlay P, Dionisi-Vici C, Fenske CD, Lee PJ, Leonard JV, Maire I, McConkie-Rosell A, Schweitzer S, Vikkula M, Van Schaftingen E.

Am J Hum Genet. 1998 Oct;63(4):976-83.

PubMed [citation]
PMID:
9758626
PMCID:
PMC1377500

Molecular diagnosis of type 1c glycogen storage disease.

Janecke AR, Bosshard NU, Mayatepek E, Schulze A, Gitzelmann R, Burchell A, Bartram CR, Janssen B.

Hum Genet. 1999 Mar;104(3):275-7.

PubMed [citation]
PMID:
10323254
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000027535.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In 2 families, Veiga-da-Cunha et al. (1998) found that patients with glycogen storage disease Ib (GSD1B; 232220) were homozygous for a 2-bp deletion (1211-1212delCT) in the G6PT1 gene, resulting in a change in reading frame after ala347.

This common frameshift mutation was reported by Veiga-da-Cunha et al. (1998) to be present in 8 GSD Ib patients. In a Turkish patient with GSD Ic (GSD1C; 232240), Janecke et al. (1999) identified the same mutation. Thus, GSD Ib and Ic result from the same mutation of the same gene.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV003841821.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.020%). This variant was predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000006926 / PMID: 9781688). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 18, 2024